All Pharma News
price-trendAsk Us
FY2023 Supplementary Material of Financial Results

FY2023 Supplementary Material of Financial Results
PRESS RELEASE
14 May 2024
Share Share
Summary of Consolidated Financial Results for the Year Ended March 31, 2024(

Summary of Consolidated Financial Results for the Year Ended March 31, 2024(
PRESS RELEASE
14 May 2024
Share Share
N-Nitroso Duloxetine Analytical Method Published in ACS Omega

N-Nitroso Duloxetine Analytical Method Published in ACS Omega
PRESS RELEASE
15 Mar 2024
Share Share
Manufacturing and Marketing Approval for Three Ingredients and Eight Items

Manufacturing and Marketing Approval for Three Ingredients and Eight Items

PRESS RELEASE
15 Feb 2024
Share Share
Notice of Acquisition of Approval for Application for Partial Change of Manufacturing and Marketing Approval for Esomeprazole Capsules concerning the Addition of a Manufacturing Plant

Notice of Acquisition of Approval for Application for Partial Change of Manufacturing and Marketing Approval for Esomeprazole Capsules concerning the Addition of a Manufacturing Plant
PRESS RELEASE
14 Feb 2024
Share Share
FY2023 3Q Supplementary Material of Financial Results

FY2023 3Q Supplementary Material of Financial Results
PRESS RELEASE
13 Feb 2024
Share Share
Chugai Pharma & Towa Pharma introduce Edirol tablet for osteoporosis treatment

Chugai Pharma & Towa Pharma introduce Edirol tablet for osteoporosis treatment
PHARMABIZ
10 Dec 2022
Share Share
Japan approves Chugai Pharma`s osteoporosis drug

Japan approves Chugai Pharma`s osteoporosis drug
BIOSPECTRUMASIA
16 Aug 2022
Share Share
Luye Pharma and Towa Pharmaceutical Enter Strategic Collaboration

Luye Pharma and Towa Pharmaceutical Enter Strategic Collaboration
PRNASIA
18 Feb 2021
Share Share
Towa Completes Acquisition of Esteve`s Generic Division

Towa Completes Acquisition of Esteve`s Generic Division
PR NEWSWIRE
31 Jan 2020
Share Share